Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2024Innovation in Science and Technology

Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors: Antidiabetics Medications for Treating Diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDevajit MohajanHMHaradhan Kumar Mohajan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mohajan et al. (2024) studied this question.

synapsesocial.com/papers/68e61dfeb6db6435875b0526https://doi.org/10.56397/ist.2024.07.10
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: From Metabolic Mechanisms to International Guidelines2026 · 1 citations
  2. 2Side effects of SGLT-2 inhibitors2025
  3. 3Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes and Beyond: Mechanisms, Pleiotropic Benefits, and Clinical Use—Reviewing Protective Effects Exceeding Glycemic Control2025 · 19 citations
  4. 4Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary2022 · 87 citations
  5. 5An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus2016 · 510 citations